Output Biosciences

Senior Computational Biologist (NYC)

New York, New York, United States

$150,000 – $250,000Compensation
Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biotechnology, Artificial Intelligence, PharmaceuticalsIndustries

Requirements

Candidates must possess a PhD in a biological field and demonstrate strong programming skills in Python. Experience with computational biology tools such as structure prediction, molecular docking, and virtual screening is required, along with experience working with Protein or Chemical Language Models. Bonus points include hands-on experience building AI/ML using PyTorch and Lightning, experience with cloud computing platforms like AWS, hands-on biology laboratory experience, contributions to peer-reviewed publications in computational biology, and knowledge of machine learning techniques applied to biological data.

Responsibilities

The Senior Computational Biologist will develop machine learning methods to extend the company's predictive and generative platform. Responsibilities include designing and executing computational pipelines to validate and prioritize de novo generated molecules using state-of-the-art tools. They will also use their deep understanding of biology to design novel therapeutics for hard-to-target proteins with generative models and analyze and integrate large-scale biological datasets. The role involves working alongside research team members and founders to develop AI systems capable of complex biological reasoning across multiple scales.

Skills

Python
Computational Biology
Structure Prediction
Molecular Docking
Virtual Screening
Protein Language Models
Chemical Language Models
Machine Learning
Data Science
Biological Reasoning
Generative Models
AI

Output Biosciences

Develops preventative therapies for chronic diseases

About Output Biosciences

Output Biosciences focuses on developing preventative therapies aimed at extending human healthspan by addressing chronic diseases such as diabetes and heart disease. The company combines biotechnology with artificial intelligence to create therapies that can be discovered and manufactured more quickly and safely than traditional methods. This allows them to bring new treatments to market in just a few months, which is much faster than the usual drug development process. Their main clients include healthcare providers, pharmaceutical companies, and research institutions seeking effective solutions for chronic disease management. Output Biosciences differentiates itself by leveraging computational biology to streamline therapy development and commercialization, generating revenue through partnerships and licensing. The goal of Output Biosciences is to fundamentally change healthcare by preventing chronic diseases before they occur.

New York City, New YorkHeadquarters
2020Year Founded
$125KTotal Funding
PRE_SEEDCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1-10Employees

Risks

Increased competition from AI-driven biotech startups threatens market share.
Regulatory scrutiny on AI applications may delay approval processes.
Rapid technological advancements may render current methods obsolete without continuous innovation.

Differentiation

Output Biosciences integrates AI and computational biology for rapid therapy development.
The company focuses on preventative therapeutics to extend human healthspan.
Output Biosciences accelerates drug development timelines, bringing therapies to market in months.

Upsides

Growing interest in AI-driven drug discovery boosts investment and partnerships.
Rise of personalized medicine creates opportunities for tailored AI-integrated therapies.
FDA's acceptance of AI-driven drug development enables faster regulatory pathways.

Land your dream remote job 3x faster with AI